This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Accenture Global Solutions Limited. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Vighnesh Paramasivam: Innovator in Pharmaceutical Molecule Screening
Introduction
Vighnesh Paramasivam is a notable inventor based in Coimbatore, India. He has made significant contributions to the field of pharmaceutical technology through his innovative work in machine learning systems. His expertise lies in leveraging artificial intelligence to enhance the efficiency of pharmaceutical molecule screening.
Latest Patents
Vighnesh holds a patent for "Machine learning systems for automated pharmaceutical molecule screening and scoring." This patent describes systems, methods, and computer-readable storage media that utilize artificial intelligence and machine learning to screen candidate pharmaceutical molecules for various pharmaceutical applications. The screening process is based on structural similarities between candidate molecules and pharmaceutical targets, such as proteins and nucleic acids. His work involves training machine learning models to categorize pharmaceutical molecules based on their chemical and physical properties, ultimately leading to more effective drug development.
Career Highlights
Vighnesh is currently employed at Accenture Global Solutions Limited, where he continues to apply his innovative ideas in the pharmaceutical sector. His work has the potential to revolutionize how pharmaceutical companies identify and develop new treatments for diseases.
Collaborations
Some of Vighnesh's coworkers include Ashish Ambasta and Dhruv Bajpai, who contribute to the collaborative environment that fosters innovation at Accenture.
Conclusion
Vighnesh Paramasivam is a pioneering inventor whose work in machine learning and pharmaceutical molecule screening is paving the way for advancements in drug development. His contributions are significant in the ongoing quest to improve healthcare outcomes through technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
